Significant Ownership of BB BIOTECH AG

Signature - Title
/s/ Christian Koch - Christian Koch/Signatory Authority
Location
Schaffhausen
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BB BIOTECH AG.

Follow Filing Activity

Follow BB BIOTECH AG and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Significant Ownership of BB BIOTECH AG

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ESPR Esperion Therapeutics, Inc. Common Stock 4.9% $8,821,598 -$227,500 9,694,064 -2.5% BB Biotech AG 04 Mar 2025
BDTX Black Diamond Therapeutics, Inc. Common Stock 4.8% $4,373,675 -$9,254,867 2,733,547 -68% BB Biotech AG 19 Mar 2025
SAGE Sage Therapeutics, Inc. Common Stock 1.9% $9,180,538 1,178,503 BB Biotech AG 13 Jan 2025
MGNX MACROGENICS INC Common Stock 0% $0 -$15,292,143 0 -100% BB Biotech AG 01 Jun 2025
AGIO Agios Pharmaceuticals, Inc. Common Stock 0% $0 -$96,033,898 0 -100% BB Biotech AG 01 Jun 2025

Schedules 13D/G Reported by BB BIOTECH AG:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .